We're excited to announce our next article, discussing many of the current peptide therapeutics currently available on the market. ?? The remarkable thing is that this marks the very beginning of a new era of small molecule therapeutics, especially as we continue to see any number of clinical trials investigating various other areas of interest in disease-research. Which is why we are so proud to be investigating our novel therapeutic AMTX-100, which will be a significant breakthrough in the use of peptides to treat immune-related diseases. Learn more in our next article! #peptides #inflammation #industrytrends #medicine
Amytrx Therapeutics, Inc.
生物技术研究
Nashville,TN 1,040 位关注者
Advancing a new class of anti-inflammatory peptides to deliver breakthrough disease-altering therapies.
关于我们
Amytrx Therapeutics is advancing a new class of peptide therapies to overcome inflammatory diseases—with a vision of providing transformative medicines to patients. Drawing on 25 years of research, Amytrx is harnessing the power of novel anti-inflammatory peptide discoveries to advance new medicines aimed at the prevention and treatment of inflammatory diseases. Our lead therapeutic candidate, AMTX-100, is bioengineered from human protein sequences that modulate the immune system by a natural process, reducing pathogenesis in a range of chronic diseases mediated by excessive inflammation. Joining forces with institutions for clinical research, Amytrx Therapeutics is dedicated to transforming the conventional treatment of chronic inflammatory diseases using biological technology that is easily understood by the human body in a way that is safe, effective, and simple to use.
- 网站
-
https://www.amytrx.com/
Amytrx Therapeutics, Inc.的外部链接
- 所属行业
- 生物技术研究
- 规模
- 2-10 人
- 总部
- Nashville,TN
- 类型
- 私人持股
地点
Amytrx Therapeutics, Inc.员工
动态
-
Congratulations to the 2024 Nobel Prize winners in Chemistry! These innovations provide enhanced tools for designing and predicting peptide structures with greater precision. This could directly lead to breakthroughs in peptide-based drug discovery, biomaterials, and therapeutics, by allowing for more efficient design processes and deeper insights into peptide behavior and interactions. #Nobel #Chemistry #Peptidetherapeutics #Immunology
The 2024 Nobel Prize in Chemistry was awarded to David Baker, Demis Hassabis, and John M. Jumper. David Baker was recognized for his work in computational protein design, while Demis Hassabis and John Jumper were honored for their contributions to protein structure prediction using artificial intelligence.?The work has contributed to the field of peptide chemistry and has significant implications for peptides due to the advancements in protein structure prediction and computational protein design. Congratulations to the award winners this year! Read more in our new blog post: https://lnkd.in/diQRqKfp #NobelPrize #Chemistry #ProteinDesign #AlphaFold2
-
ICYMI: Peptides are the future when it comes to treatment of diseases. These short chains of amino acids are known as the building blocks of proteins. Imagine them as small pieces of a bigger puzzle (the bigger puzzle being proteins). Because they are smaller, they can do specific jobs more easily in the body and get into to difficult places, like hard to penetrate cells. In medicine, peptides are used to help the body perform specific functions, such as: ?? Healing and Repair: Some peptides help the body repair tissues, like muscles or skin, after injury. ? Hormone Regulation: They can be used to mimic hormones (like insulin) and help regulate processes like blood sugar levels. ?? Immune Boosting: Certain peptides can enhance or support the immune system to fight infections or diseases. ? Anti-Aging: Some are used in skincare or treatments to promote healthier skin by stimulating collagen production. ? And some can even fight back against inflammation, much like our very own peptide therapeutic. In short, peptides act like little helpers in medicine, targeting specific areas of the body to treat or improve certain conditions with the ability to help patients across diverse health conditions. We we believe this is only the beginning. #peptides #healing #patientcare
-
-
We're excited to share the next article in our Peptide Therapeutics. Researchers are only just now touching the tip of the iceberg. Over the next several years, we're bound to see significant breakthroughs - some of which various patients are already reaping the benefits of. Join us in learning more about the future innovations in this exciting area! #peptidetherapeutics #trending #pharmaceuticals
-
We have compiled a variety of useful tools for the peptide researcher, including: ? Peptide properties calculators ? Peptide drawing tools ? 2- and 3-D structure generators ? Peptide databases ? Glossaries of clinical trial terms and acronyms Find that and more here: https://lnkd.in/eMYHg7rk
-
There are many obstacles the peptide therapeutic industry has historically faced, but new innovative research is overcoming a number of them. In our next article series, learn what common challenges researchers and pharmaceutical companies have addressed and where the potential for these new therapeutics are shaping up to be some of the most powerful new pharmaceuticals on the market! #peptidetherapies #learnmore #pharmaceuticalresearch #smallmolecules
-
We’re excited to be returning to BIO 2024 - Hosted by the Bio International Convention! Meet us in San Diego as we share key updates about our recent Phase 2b Clinical Trial in atopic dermatitis. We still have a few open slots and would love to meet with you. Connect with us through the one-on-one partnering event or DM us directly via Linkedin! #BioInvestor2024
-
-
?? Fresh off the press: exciting progress in the fight against fibrosis using novel peptide therapeutics! Researchers at Vanderbilt University Medical Center, including Dr. Manuel Chiusa and Dr. Ambra Pozzi, have made a significant breakthrough in understanding and potentially treating this challenging condition. Their recent study, published in the Journal of Clinical Investigation, reveals promising results in blocking the protein FUS from entering the nucleus of kidney cells, leading to reduced collagen levels—a key factor in fibrosis. The team's work suggests that a novel peptide, CP-FUS-NLS, could be a viable therapeutic option for fibrosis in organs like the kidney and liver. This achievement, supported by grants from the NIH and the U.S. Department of Veterans Affairs, highlights the impactful collaboration between researchers like Jacek Hawiger, MD, PhD (and Co-Founder of Amytrx Therapeutics), and their teams. Their dedication and innovative approach offer hope for millions affected by fibrosis worldwide. Congratulations to Manuel Chiusa, Ambra Pozzi, and the entire team for their groundbreaking work! #FibrosisResearch #MedicalAdvancements #VUMC #PeptideTherapy
-
You may recognize the month of March as Women's Month - but it's also Autoimmune Awareness Month. This March, let's raise awareness about the impact of autoimmune conditions on women's health. Autoimmune diseases are a group of more than 80 chronic illnesses, including lupus, rheumatoid arthritis, and multiple sclerosis, where the body's immune system attacks its tissues. Many of these diseases disproportionately affect women. Let's work together to support women's health and those affected by autoimmune conditions by developing new therapeutics. May Spring be fruitful! #WomensMonth #AutoimmuneAwareness #AutoimmuneDisease
-
-
We know you were anxiously awaiting our next article, Advantages of Peptide Therapeutics. Peptides are more than just small chains of amino acids - they are incredibly diverse compounds capable of treating many diseases. If you thought small molecules might be the future of medicine, just wait until you read about what makes peptides so special. Let us know your thoughts in the comments! #peptidetherapy #smallmolecules #drugdevelopment #precisionmedicine